EAHAD/LinkedIn
May 21, 2026, 07:23
EAHAD Highlights the Power of Clinical Trials in Haemophilia
EAHAD (European Association for Haemophilia and Allied Disorders) shared a post on LinkedIn:
“This Clinical Trials Day, we recognize the critical role that clinical research plays in driving innovation and improving outcomes for people living with haemophilia.
Within this context, the EAHAD Gene Therapy Trials Database provides a publicly accessible resource that consolidates the latest published gene therapy data, with a particular focus on safety outcomes.
By bringing structured and up-to-date evidence into one place, the platform supports a clearer understanding of ongoing and completed clinical research in the field.
Access the database.”
Stay updated with Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?